Cargando…
The potential development of drug resistance in rheumatoid arthritis patients identified with p53 mutations
Autores principales: | Qiu, Congling, Chan, Joyce Tsz Wai, Zhang, David Wei, Wong, Io Nam, Zeng, Yaling, Law, Betty Yuen Kwan, Mok, Simon Wing Fai, De Seabra Rodrigues Dias, Ivo Ricardo, Liu, Wenfeng, Liu, Liang, Wong, Vincent Kam Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404951/ https://www.ncbi.nlm.nih.gov/pubmed/37554177 http://dx.doi.org/10.1016/j.gendis.2023.02.007 |
Ejemplares similares
-
Potential enhancement of post-stroke angiogenic response by targeting the oligomeric aggregation of p53 protein
por: Tam, Hoi Hei, et al.
Publicado: (2023) -
Ca(2+) signalling plays a role in celastrol‐mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats
por: Wong, Vincent Kam Wai, et al.
Publicado: (2019) -
New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of Autophagy
por: Law, Betty Yuen Kwan, et al.
Publicado: (2016) -
Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers
por: Law, Betty Yuen Kwan, et al.
Publicado: (2016) -
New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers
por: Law, Betty Yuen Kwan, et al.
Publicado: (2017)